Pedro Beltran, Ph.D. is the Senior Vice President of Oncology at BridgeBio. Previously he held senior roles in oncology at both UNITY Biotechnology and Amgen. Prior to joining the pharmaceutical industry, Dr. Beltran was a part of the research team at University of Miami, where he did his post-doctoral fellowship. He received his B.S. from Florida Institute of Technology and his Ph.D. from the University of Texas Health Science Center at Houston.
Current role